Market Place
Sourcing Support
“Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”
This week, SpeakPharma interviews Denise Sutton, Chief
Operating Officer and Site Head at Quotient Sciences’ Nottingham ...
“We have built considerable expertise in GLP-1 drug development through our oral peptide programs”
This week, Speak Pharma interviews Dr. Andrew Lewis,
Chief Scientific Officer at Quotient Sciences, a drug development and man...
“Our Translational Pharmaceutics platform shortens drug development timelines by over 12 months”
This week, SpeakPharma interviews John McDermott, Vice
President of Scientific Consulting at Quotient Sciences, a drug develop...
“Quotient Sciences’ integrated approach to drug development accelerates molecules to IND & beyond”
This week,
SpeakPharma interviews Eleanor Row, Executive Director of Commercial at Quotient Sciences, a global drug developmen...
“For orphan drugs, we identify a patient-ready formulation in less than half the time.”
This
week, SpeakPharma interviews Dr. Peter Scholes, Chief Scientific Officer, Quotient Sciences, who talks about orphan drugs...
